Discover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.
There are simple tools that can help us achieve the best employment contract.
Health care costs continue to rise in this country. According to a study by the Peterson Center on Healthcare and the Kaiser Family Foundation, health care spending totaled $3.8 trillion in 2019, $11,582 per person.
Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
The PC Project provides patients with access to the International PC Research Registry for clinical help with their rare and painful skin condition.
This week's edition of the Mainstream Patients features stories about FDA's latest approval, abortion, and more.
Chargemaster lists may encourage patients to shop around for services, but the authors of this report said the implications of this change for dermatology are not well-defined.
Minimally invasive method outperformed tape stripping in a recent study.
Jodi Westfall, NP, explains how she improves common skin conditions traditionally and from a metabolic perspective.
Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.
An expert details the ways to gain and retain new practice staff.
Joseph Zabinski, PhD, MEM, of OM1, shares insights at AAD into how artificial intelligence can mature and be a positive tool for disease detection.
The results of physician trials led by the AAFP Innovation Lab are very promising.
Ashley Buehnerkemper, director of marketing at VitalSkin Dermatology, discusses what steps you can take to make public relations an active piece of your practice marketing.
Challenges with overlaps in diagnosis and classification based on rosacea’s 4 subtypes are creating a new focus on features of the condition in each patient. A pipeline of new drugs awaiting FDA approvals could further expand options.
American Hair Loss Association urges caution.
De Benedetto shares her expertise on new discoveries in the science of atopic dermatitis at RAD 2023.
Expert tips and techniques on the best ways to select, hire and retain the right people for your team.
What are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.
Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.
In rare cases, chromhidrosis may be associated with underlying medical conditions, such as hyperthyroidism, dermatitis herpetiformis, and multiple myeloma.
Susan Taylor, MD, explained the current state of diversity in clinical trials, what is going well, and opportunities to improve.
Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.